AVIR
Atea Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$6.10
+0.00 +0.00%
🌙 3월 13일 5:53 PM ET (한국 3/14 06:53)
$6.13
+0.03 ▲ +0.49%
| Index | RUT | P/E | - | EPS (ttm) | -1.95 | Insider Own | 21.22% | Shs Outstand | 0.08B | Perf Week | 3.57% |
| Market Cap | 0.49B | Forward P/E | - | EPS next Y | 28.24% | Insider Trans | - | Shs Float | 0.06B | Perf Month | 36.77% |
| Enterprise Value | 0.19B | PEG | - | EPS next Q | -0.56 | Inst Own | 68.64% | Short Float | 12.55% | Perf Quarter | 93.04% |
| Income | -0.16B | P/S | - | EPS this Y | 0.52% | Inst Trans | 6.31% | Short Ratio | 14.73 | Perf Half Y | 84.85% |
| Sales | 0.00B | P/B | 1.73 | EPS next 5Y | 20.9% | ROA | -40.61% | Short Interest | 7.88M | Perf YTD | 70.87% |
| Book/sh | 3.53 | P/C | 1.61 | EPS past 3/5Y | -11.75% -71.02% | ROE | -44.34% | 52W High | -5.43% ($6.45) | Perf Year | 99.35% |
| Cash/sh | 3.79 | P/FCF | - | Sales past 3/5Y | - | ROIC | -57.49% | 52W Low | 148.47% ($2.45) | Perf 3Y | 81.01% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 2.37% | Gross Margin | - | Volatility(W/M) | 5.78% 5.72% | Perf 5Y | -91.01% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.3 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.82 | EPS Q/Q | -44.62% | Profit Margin | - | RSI (14) | 82.61 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.82 | Sales Q/Q | - | SMA20 | 19.05% ($5.12) | Beta | 0.14 | Target Price | $8.83 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | 40.73% ($4.33) | Rel Volume | 0.96 | Prev Close | $6.1 |
| Employees | 55 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -17.53% - | SMA200 | 71.97% ($3.55) | Avg Volume(3M) | 0.53M | Price | $6.1 |
| IPO | 2020/10/30 | Option/Short | Yes/Yes | Trades | 5890 | Volume | 511,337 | Change | - |
뉴스 로딩 중...